Documents
Application Sponsors
ANDA 078751 | ANI PHARMS INC | |
Marketing Status
Discontinued | 001 |
Discontinued | 002 |
Application Products
001 | TABLET;ORAL | EQ 1MG BASE | 0 | NARATRIPTAN | NARATRIPTAN HYDROCHLORIDE |
002 | TABLET;ORAL | EQ 2.5MG BASE | 0 | NARATRIPTAN | NARATRIPTAN HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2010-07-07 | |
LABELING; Labeling | SUPPL | 2 | AP | 2012-04-24 | |
LABELING; Labeling | SUPPL | 5 | AP | 2015-07-15 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 15 |
SUPPL | 5 | Null | 15 |
CDER Filings
ANI PHARMS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 78751
[companyName] => ANI PHARMS INC
[docInserts] => ["",""]
[products] => [{"drugName":"NARATRIPTAN","activeIngredients":"NARATRIPTAN HYDROCHLORIDE","strength":"EQ 1MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"NARATRIPTAN","activeIngredients":"NARATRIPTAN HYDROCHLORIDE","strength":"EQ 2.5MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"NARATRIPTAN","submission":"NARATRIPTAN HYDROCHLORIDE","actionType":"EQ 1MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"NARATRIPTAN","submission":"NARATRIPTAN HYDROCHLORIDE","actionType":"EQ 2.5MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)